RESEARCH DOSSIER
Long-Term Care Premium Rate Stability and Repricing Governance
Abstract. Premium stability is a core intertemporal property of long-term care insurance. The insurer commonly promises benefits that may be claimed decades after underwriting, whereas the policyholder commits to a sustained schedule of premiums under changing health, income, family circumstances, interest rates, care systems, and law. The resulting contract places unusual weight on the accuracy of original morbidity, mortality, lapse, benefit-utilization, expense, and investment assumptions. Subsequent repricing transforms forecast error into an institutional decision with actuarial, legal, distributional, and solvency consequences. This monograph examines how that decision should be understood, measured, justified, supervised, and communicated. The research combines formal prospective cash-flow reasoning, experience-study design, longitudinal selection analysis, documentary comparison of U.S. model regulation and state approaches, the NAIC multistate review architecture, and international actuarial and reporting standards. It distinguishes rate stability, price adequacy, contract renewal provisions, insurer capital strength, and real benefit adequacy; it examines the tension between block-level actuarial need and policyholder-level affordability. Reproducible hypothetical calculations explain lifetime present-value gaps, interest-rate sensitivity, cumulative compounding, and the limits of unadjusted actual-to-expected ratios. Empirical evidence includes industry experience publications, a carrier survey of 2024 filings, and scholarly analyses of lapsation, asymmetric information, public-insurance interaction, and consumer decisions. The central finding is that a premium-change percentage alone is an inadequate measure of regulatory success. A credible review must reconcile a time-stamped original pricing basis with updated experience, segment-level exposures, permissible contract mechanisms, anticipated behavioral responses, the financial condition of the issuing entity, state-specific approval law, and the continuing economic value of benefits. Evidence that an increase is actuarially supportable establishes an essential input to a regulatory decision; it does not mechanically dictate the timing, allocation, or consumer alternatives of that decision. The work develops a transparent analytical synthesis within established actuarial and supervisory methods, without proposing a new theory or asserting empirical originality beyond its documentary and hypothetical analysis.
Keywords: Long-term care insurance; premium rate stability; repricing; rate stabilization; lifetime loss ratio; actuarial assumptions; voluntary lapse; morbidity; mortality; interest-rate risk; multistate rate review; reduced benefit options; contingent nonforfeiture; financial solvency; policyholder protection; regulatory governance.
Introduction
A long-term care insurance contract links present financing to possible future losses of functional independence. Care may take the form of assistance at home, in community settings, or in residential institutions; contractual reimbursement or indemnity depends on policy definitions, elimination periods, covered services, benefit limits, and claim triggers. A current premium finances the risk of a future payment stream whose timing and severity may remain uncertain for decades. This temporal structure makes the quality and revision of original assumptions a first-order subject of insurance economics rather than a mere operational pricing detail.
In the United States, a substantial stock of traditional stand-alone long-term care insurance contracts remains in force after many insurers have withdrawn from new sales. The NAIC long-term care overview describes the market's evolution and regulatory initiatives, while the NAIC's 2016 CIPR study reconstructs the historical weaknesses of initial pricing and the emergence of rate-stabilization provisions. The scope of this monograph is the governance of in-force premiums under contracts and law permitting class-level adjustment. A separately priced hybrid life/LTC contract, a public long-term care program, and a disability-income policy have distinct cash flows and contractual constraints; their evidence cannot simply be transferred to the stand-alone LTC block.
A central conceptual problem is the use of the word stability. From the policyholder perspective, stability denotes an affordable and predictable payment path. From the insurer perspective, it denotes the ability to maintain an economically adequate rate schedule without repeated corrective action. For a regulator, stability includes legally defensible decisions, consistency across comparable cohorts, and avoidance of solvency deterioration that would endanger the promised benefits. These perspectives arise from the same contract, but they are evaluated using different evidence and time horizons. An insurer can charge an initially stable but inadequate premium; an increase can improve solvency while creating lapse and coverage reductions; a low reported loss ratio can coexist with significant emerging claims.
The study asks three connected questions. First, which original records and exposure measures can establish why actual and projected experience diverge from pricing? Second, how can a revised premium be calculated and distinguished from the allowed, phased, or actually collected premium? Third, how should regulatory review evaluate insurer sufficiency and policyholder consequences when products, states, generations of policies, and public care systems differ? The analytical approach is a source-based synthesis of actuarial standards, peer-reviewed market research, official supervisory frameworks, and transparent illustrations. It does not use confidential insurer microdata, assert national causal effects from selective samples, or substitute a hypothetical formula for a filed actuarial memorandum.
The international dimension is deliberately specific. General principles of liability projection, data governance, claims-state transitions, discounting, and public disclosure travel across jurisdictions. The legal authority to vary an existing LTC premium does not. The IAIS Insurance Core Principles frame supervisory objectives across markets, and IFRS 17 supplies an insurance-contract reporting framework in applying jurisdictions. Neither source creates a worldwide power to reprice a private LTC policy. Comparative analysis therefore identifies what is functionally comparable before interpreting institutional differences.
Conceptual Foundations and Historical Development
The economic promise and the long duration of the contract
Traditional LTC insurance frequently combines an extended premium-paying period with claims concentrated at later ages. Contract provisions specify the circumstances in which a daily, weekly, monthly, or pooled benefit becomes payable; a waiting or elimination period and a limit on duration or total benefits constrain the liability. Some products provide inflation growth in nominal benefits, and some suspend premiums while the insured receives qualifying benefits. The consumer descriptions issued by the California insurance department and the NAIC consumer guidance demonstrate why a nominal benefit maximum, annual premium, and total protection cannot be treated as interchangeable amounts.
Pricing must anticipate transitions among healthy in-force, disabled in-force, recovered, lapsed, and deceased states, together with spending intensity conditional on claim status. Actual designs can require richer categories, including home versus facility care, cognitive impairment, waiver-of-premium status, and separate termination reasons. A multistate model is an accounting and stochastic representation; its states must correspond to observed eligibility and cash-flow definitions. The traditional term level premium usually refers to a schedule that does not increase solely because the individual has another birthday or deteriorating health. As the New York LTC consumer guide explains, a policy may still permit a regulator-approved change for a class of insureds when original assumptions have materially changed.
One insured's premium may therefore remain fixed by individual risk history yet change because the block to which the contract belongs has undergone a permitted class adjustment. A guaranteed level or renewal right, a guaranteed premium for a specified period, and an irrevocably fixed premium are legally distinct promises. The filing cannot be judged without the issued policy form, endorsements, original rate table, implementation dates, and applicable state rules.
Insurance economics and incomplete protection
The economic literature shows why the desirability of insurance against catastrophic care costs does not imply a large or frictionless private market. Brown and Finkelstein's 2007 pricing and coverage analysis documents meaningful loads and incomplete protection in observed U.S. policies; their 2009 review of the evidence synthesizes supply and demand explanations for limited take-up. The Medicaid interaction study analyzes the implicit taxation of private coverage by public means-tested support in the model it studies. These papers address demand and market design; their empirical magnitudes are sample- and period-specific and should not be repurposed as present-day national rates.
A person deciding whether to maintain a policy compares its prospective protection and contractual options with the marginal cost of premiums, alternative savings, family support, public benefits, and the effect of losing future insurability. The decision is dynamic because the insured may have accumulated the right to valuable future benefits while premiums have already been paid for years. It follows that a repricing action can have effects larger than the immediate increase in dollars: it may change the insured's optimal care-financing plan, opportunity to remain insured, and consumption in retirement.
Why earlier premium schedules became unstable
The 2016 regulatory history distinguishes older minimum-loss-ratio arrangements from the rate-stabilized generations introduced through the NAIC Long-Term Care Insurance Model Regulation. The 2000 changes replaced a simple initial minimum loss-ratio constraint with certification of premiums under moderately adverse conditions and a dual treatment of original and increased premiums for certain rate-increase tests. The 2014 changes strengthened initial margins, experience monitoring, and benefit-reduction and nonforfeiture provisions. These are model texts whose effect depends on state adoption and policy issue date; the NAIC model-law catalog lists Model 640 and Model 641 without turning every model provision into a uniform national statute.
Rate-stabilization reforms respond to a structural predicament. A block may have been priced using an expected voluntary lapse level, mortality, morbidity, interest earnings, and expenses that later depart materially from realization. If fewer insureds lapse and fewer die while healthy, more contracts survive to ages at which claims are common; higher incidence, longer claim duration, care inflation, or reduced asset earnings can compound the shortfall. The observed change has to be decomposed. A low voluntary lapse assumption is not automatically desirable or undesirable for welfare: it supports continuity of protection, while reducing the insurer's ability to rely on premiums collected from people who leave without claiming.
The regulatory object is an in-force class
An in-force premium review is not a new-business price filing. It involves persons whose underwriting took place in the past and whose opportunities to replace coverage have changed. The proper unit is a well-defined cohort or policy form and state-specific population, with transparent experience and projection. A nationwide block can contain identical contract language yet different cumulative approved increases by state, resulting in unequal future premium schedules. The NAIC multistate rate review description identifies coordination as a response to this fragmentation.
Regulatory approval also differs from actuarial projection. An appointed or company actuary may calculate a supportable indicated increase using data and chosen assumptions. A department can require different supporting evidence, limit or phase an increase, or condition approval under its applicable law. The New York LTC rate methodology explicitly combines benefit proportionality, financial information, and solvency in its review. The analytical distinction between indicated, filed, approved, implemented, and collected changes is maintained throughout this study.
The dimensions of rate stability
Four measurable dimensions are useful for classifying an observed outcome. Nominal payment stability concerns the magnitude and timing of the required premium. Actuarial stability concerns whether projected claim and expense cash flows remain financeable by assets, reserves, and future premiums. Coverage stability concerns whether the insured continues to possess comparable real protection after the intervention. Institutional stability concerns consistency, transparency, and foreseeable review practices. These dimensions are analytical descriptions of existing concerns, not a new theory. A regulator should report them separately because improvement in one dimension can occur with deterioration in another.
Initial Assumptions and Experience Gaps
Establishing the original pricing basis
The starting point of a scientific repricing audit is a reproducible original basis: issue years, entry ages, underwriting categories, state of issue, benefit riders, premium mode, initial rates, expense loading, initial and renewal commissions, investment assumptions, premium waiver, termination assumptions, projected claims, and pricing margin. Later assumptions should be labeled by the date at which they were adopted, the experience window on which they rest, and the justification for extrapolation. Current data do not reveal the original decision unless the historical pricing memo or archived filing can be reconciled to the in-force policies.
The December 2025 MSA Framework calls for historical rate changes and actuarial memoranda, including lifetime earned-premium and incurred-claim projections and detailed exhibits, alongside original assumptions and experience. This design recognizes a vital evidentiary distinction: a present-day best estimate may be internally coherent while failing to explain why an earlier pricing schedule proved inadequate. A meaningful explanation requires a bridge from original assumptions through observed outcomes to the revised projection.
Defining exposure and observations
A policy count is not necessarily a policy-year of exposure. A contract in force for three months contributes approximately a quarter of a year to time-at-risk; a claim-incidence denominator may exclude intervals already disabled; a premium denominator may include or exclude waived-premium periods according to the stated measure. Let E denote eligible active-life years and N new qualifying claims; a crude incidence estimate is N/E. Its validity depends on precise eligibility definitions, data completeness, and the treatment of multiple claims for the same insured. Claim count, care episodes, benefit payments, and unique claimants are different observables.
A simple reproducible example uses 10,000 eligible person-years and 250 incident claims. The observed incidence estimate is 250/10,000 = 2.5% per eligible person-year. Against an original assumption of 2.0%, the expected claim count is 200 and the crude actual-to-expected ratio is 250/200 = 1.25. If events were independent and Poisson, a rough standard error for the ratio would be square root of 250 divided by 200, about 0.079; a normal-approximation interval would be about 1.10 to 1.40. LTC event dependence, delayed reporting, age composition, calendar shocks, and repeated claims may invalidate that approximation. No empirical significance claim is drawn from this synthetic illustration.
The ASOP 23 Data Quality requires practitioners within its scope to consider the suitability of data and limitations of their review. For this research, a credible experience table retains denominator definitions, policy movement reconciliations, the distinction between duration and calendar time, and controls for missing benefit or care-setting fields.
Mortality, lapse, and persistence
Voluntary lapse and mortality are competing exit processes from a block. A policy that terminates because the insured dies is not a voluntary lapse; a healthy insured moving into a claim state is not a conventional active-life lapse. The SOA–LIMRA 2000–2016 persistency report uses observations contributed by eighteen companies and separates lapse, mortality, and termination activity. The underlying calendar window and contributing population are essential to interpretation. Such studies provide experience benchmarks, but the forecast for an individual insurer must consider contract generation, underwriting, benefit mix, and its own risk selection.
A reduced healthy-life mortality rate can increase the surviving number of insureds reaching the claim-intensive ages; a reduced voluntary lapse rate can do the same. The effect on the lifetime loss ratio must still be calculated with both premium and claim changes. More surviving policyholders may also continue paying premiums. The net effect depends on the pattern, not on the sign of one isolated decrement.
Selection further complicates lapse analysis. Friedberg, Hou, Sun, and Webb's 2023 lapse study uses Health and Retirement Study evidence to associate cognitive impairment with higher lapse probability and to investigate welfare costs. Finkelstein and McGarry's private-information study demonstrates that heterogeneity in risk information and insurance preference can conceal selection in aggregate coverage-risk correlations. Taken together, the studies support modeling lapse as potentially informative about future claims. They do not establish a universal causal lapse elasticity to a particular premium increase.
Morbidity and claim continuation
LTC morbidity comprises distinct mechanisms: the probability of entering a qualifying state, conditional severity, care-setting choice, service intensity, movement among functional states, recovery, and termination of an open claim through recovery or death. An increase in total paid benefits can result from more incident claims, a higher average reimbursement rate, longer paid durations, or contractual inflation riders; those components should be measured separately. A claim-cost method that models total annual paid benefits and a first-principles model that separately represents onset and duration can produce similar totals while having different sensitivities.
The SOA long-term care studies catalog identifies experience tables and research on incidence, persistency, and claim outcomes. The 2000–2023 experience data request explicitly targets standalone policies, including group and individual coverage, and excludes hybrid products from that collection. Such population boundaries matter: combining accelerated-benefit life policies with conventional stand-alone LTC claims without a compatible exposure definition produces misleading trend inferences.
Interest assumptions and asset-liability interaction
LTC premiums may be collected long before claims. The longer the horizon, the greater the sensitivity of present value to investment return and discounting conventions. For a hypothetical amount payable 20 years from valuation, present value at 3% is 1/(1.03)^20 of nominal payment, and at 5% it is 1/(1.05)^20. The 3% valuation is about 1.47 times the 5% valuation for that single payment. This is a discounted-liability comparison, not an insurer-wide income statement and not evidence of any actual portfolio yield.
Asset adequacy requires a fuller calculation: asset cash flows, reinvestment, credit losses, expenses, claims, duration mismatch, and liquidity must be evaluated together. ASOP 22 asset adequacy guidance describes scenario testing of reserves and assets within its U.S. professional scope. The IFRS 17 measurement principles require current insurance fulfillment cash-flow estimates and recognize financial and service components in applicable accounting regimes. Neither a discount-rate sensitivity nor an IFRS presentation figure can be substituted directly for an LTC premium-rate indication.
Cost inflation, utilization, and care systems
A contract with an inflation rider may increase benefit limits mechanically, but the actual unit cost of care follows labor markets, service composition, technology, public financing, and local supply. If modeled cost intensity grows at 2% annually while realized cost grows at 4%, a unit-cost index after twenty years is (1.04/1.02)^20, approximately 1.47 times the forecast. This illustration isolates cost per unit of service; actual claim cost also depends on incidence, benefit caps, covered days, and site-of-care mix.
The OECD long-term care spending comparison warns that the accounting boundary between healthcare and social care differs among jurisdictions. The OECD long-term care workforce indicators likewise shows large differences in paid staffing and measures of formal care supply. An international mortality or care-cost aggregate cannot therefore be treated as a direct premium factor for a U.S. policy form. Comparative data are relevant to structural pressures and alternative scenarios, while legal and actuarial calibration remains product-specific.
Experience timing and exceptional shocks
Calendar years of unusually high death, changed facility admission, and disrupted home care can alter active-life counts, claim incidence, claim termination, and payment patterns simultaneously. A mechanically fitted short-window trend can embed transitory shocks in a fifty-year projection. The research design should distinguish occurrence, report, payment, and valuation dates; separately display pandemic-period and adjacent experience when available; and explain normalization without erasing actual incurred losses. The 2025 LTC rate landscape analysis reports that carriers differed in their treatment of COVID-era experience, including exclusion or selective normalization. That is evidence of modeling heterogeneity, not a universal instruction to omit those years.
Supervision and Policyholder Impact
Supervisory objectives and institutional authority
Long-term care rate review sits at the intersection of solvency supervision and conduct obligations. An unsound block can ultimately fail to meet long-dated promises; an unreasonably large or poorly explained increase can deprive insureds of affordable access to coverage built up over decades. The IAIS supervisory principles address financial soundness and fair conduct in broad terms. Their application to a particular repricing decision depends on national and subnational law.
The U.S. is a highly instructive case because state departments retain rate-approval powers and the model-law adoption process creates differences among policy cohorts. The NAIC model 641 catalog and NAIC's 2026 LTC summary establish the supervisory lineage. The analytical task is to distinguish the model's normative architecture from the rules actually effective in the state of issue, as of the relevant policy issue and change date. The existence of a multistate advisory process does not itself override state decisions.
The multistate actuarial review architecture
The December 2025 LTCI MSA Framework describes a coordinated review by actuarial specialists producing an advisory report for voluntarily participating state insurance departments. It covers a defined in-force rate proposal, information submission, review criteria, and the relationship to later state-level filings. The MSA Advisory Report is an input that departments may use; final disposition remains with the relevant state regulator under its law. This distinction is fundamental to legal accuracy.
The Framework's documentation expectations include historic changes, claims and premium projection, benefit design, lapse and waiver assumptions, original pricing parameters, A/E differences, and relevant experience and sensitivity. Its coordination objective is significant: a single block may face divergent historical approvals in different states despite common underlying claim risk. A multistate analysis may improve consistency and reduce duplicative actuarial review, yet implementation differences persist when states exercise separate legal responsibilities.
The NAIC 2026 working-group charges include monitoring the MSA approach and developing more consistent LTCI actuarial guidance and experience reporting. This is a current institutional work program, not evidence that all states use one identical methodology or that all insurers receive the same increase.
New York: a documented prior-approval approach
The New York DFS LTC review methodology provides a concrete regulator-authored account of how rates must be reasonably related to benefits and self-supporting under the cited state-law framework. The Department examines historical and future premiums and incurred claims, liabilities, reserves, financial results, and the actuarial basis of the proposal. Its consumer explanation separates individual aging and health changes from allowable class-level changes. A policyholder therefore needs both the state decision and the specific policy documents to understand why a premium has changed.
The public LTC rate filing portal posts application summaries and public comment opportunities, creating observable procedural evidence that can be studied by filing and date. A research audit should retain the SERFF identifier, initial request, supplemental submissions, comment period, eventual decision, and actual notice, rather than coding an initial filing as an approval. Documentary availability of a filing is not proof that an increase took effect.
California: history and consumer interpretation
The California rate history database collects reported LTC increase information from licensed carriers and cautions that absence of a prior increase does not imply absence of future increases. The California consumer guide states that currently offered policies under CDI jurisdiction are subject to rate-stabilization review and additional justification requirements. Regulatory comparisons must separate products currently offered from legacy closed blocks and distinguish a state's reported approval history from the actual premium trajectory of a given insured.
Historical experience may be affected by the vintage of a policy, multiple state jurisdictions, approved phase-ins, form mergers, and the naming of insurer entities. Rate history is informative but cannot independently determine current actuarial adequacy or the prospective value of the promised benefit. A sophisticated public presentation would connect rates, form identity, and benefit changes while preserving privacy.
Reduced benefit options and contingent protection
A policyholder faced with a higher premium may be offered a smaller daily or monthly benefit, a shorter benefit period, reduced inflation protection, or another contractually and regulatorily permitted alternative. Some circumstances provide contingent nonforfeiture, often associated with a specified premium-increase trigger, under which coverage or a limited benefit may persist after the insured stops paying. The rules depend on product issue date and applicable jurisdiction; the NAIC's account of 2014 reforms explains the historical tightening of consumer benefit options without implying that its model automatically applies to older policies in every state.
The Cude, Groshong, and Burns interviews examine how financial planners perceive the complexity of reduced-benefit choices. Interviews provide rich qualitative evidence about advice, framing, and communication, rather than a representative estimate of every policyholder's decision. The 2024 carrier survey reports 11.9% of impacted policyholders selected an RBO in its data. Neither figure tells the regulator how much of the policy's real value an individual election preserved.
A comparison of options should therefore translate the contractual schedule into a projected benefit path. A nominal daily maximum of 200 with a 3% annual compounded benefit adjustment becomes about 362 after twenty years, while a fixed 200 maximum stays 200. Both are hypothetical cash-limit calculations; actual reimbursement depends on care need, claim eligibility, purchased benefit design, and available care. A smaller premium may represent a rational preference for liquidity, but the reduction of future real protection should be made visible.
Affordability, risk pooling, and distributional fairness
An older insured with impaired health and limited liquid income can face a much larger welfare loss from lapse than a younger or wealthier insured who has alternatives. Policyholders nevertheless differ in expected care needs, assets, public-program eligibility, and family circumstances. The Brown and Finkelstein market review shows that limited demand cannot be understood solely by looking at premium arithmetic. A rate change also alters how private benefits interact with public care financing.
Distributive assessment needs caution. A class-level percentage increase may apply identically while its real burden differs by household resources. A differentiated increase may better reflect expected claims but conflict with jurisdictional fairness tests or make the remaining portfolio smaller and less diverse. Fairness is therefore not reducible to an equal percentage or to exact actuarial segmentation. The applicable legal rule, the objective of ensuring payment of promised claims, the treatment of policyholders who cannot afford the revised schedule, and the transparency of options must be considered together.
Communication as a substantive control
A technically correct rate memorandum can still produce poor consumer decisions if the notice is late, obscure, or organized around an anchoring premium change rather than the consequences of available choices. The ASOP 41 communication standard provides professional expectations for explaining findings and material assumptions within its scope. The NAIC-sponsored consumer-choice research highlights decision difficulty in real rate-increase situations.
An adequate notice should identify the original premium, new amount, precise effective date, cumulative history when relevant, the distinction between requested and approved changes, and every available reduced-benefit or nonforfeiture election. Where choices are irreversible or materially change the inflation rider, that consequence should be made clear. An insurer's customer-service process and the regulator's complaint channel are relevant evidence of institutional accessibility; the scientific analysis cannot infer informed consent merely from the absence of complaints.
Data, Legal, and Model Validation
An auditable source-to-decision trail
A valid research chain begins with a precisely defined claim and its relevant document: a statute or regulation for legal authority; a rate memorandum and underlying exhibits for the insurer's indication; a regulator's order for approval; and premium notices and administrative records for implementation and consumer response. Replacing a final order with a press release, an industry sample with a national estimate, or a model text with binding state law breaks the evidentiary chain. Scientific reproducibility also requires preserving document versions and exact valuation dates.
For an actual case study, the minimum analytical dataset would include policy form, state, issue year, attained and issue-age distribution, benefit configuration, number and duration of exposed policies, actual and expected decrements, incurred and paid claims, reserves, premium schedules, original and updated projection basis, requested and approved rate adjustments, implementation timing, and policyholder choices. The NAIC framework's filing checklist and actuarial data-quality standard provide complementary reasons to insist on these fields. Personal data should be protected through lawful aggregation and disclosure controls.
Cohort effects and calendar effects
A significant risk of false inference arises when older cohorts contain different benefits and underwriting practices from younger cohorts. Comparing their raw claim rates can confuse attained age, time since issue, calendar year, selection duration, and contract design. A practical statistical design uses strata for issue year and product form, age- and duration-specific exposure, and a calendar-period effect where credibility permits. A multistate or semi-Markov process can distinguish entry into disability, claim continuation, recovery, and termination; a simpler claim-cost model may be preferable if available data cannot identify all transitions.
A/E ratios require explicit denominators and original expected values. For example, an A/E ratio of 1.20 for an old inflation-protected block and 0.95 for a newer non-inflation block cannot be averaged without considering exposure, expected claims, and contract mix. Weighting by expected claim count gives a different answer from weighting by policy count. Aggregation should preserve its weighting and any exclusions. The SOA experience-study scope is a reminder that even an industry dataset is defined by participating policies and observation rules, not by the phrase long-term care in isolation.
Model validation and nonidentification
A deterministic premium indication is conditional on assumptions that may be jointly uncertain. Higher claim incidence, lower mortality, and lower voluntary lapse can all increase late-age claims, while interest and expense shifts affect different cash-flow components. Correlated changes can make a set of one-factor stresses understate joint tail outcomes. Formal uncertainty analysis should therefore include plausible combinations rather than only isolated perturbations, with governance explaining the evidentiary basis of dependence assumptions.
Not every observed deterioration identifies a causal mechanism. High claims after an increase may reflect higher-risk insureds remaining, claim development, care-cost changes, or the aging of the block. The observational process often lacks a comparable untreated control. The Finkelstein–McGarry selection findings warn that aggregate coverage-risk correlation may be deceptive, and the longitudinal lapse findings show how cognitive condition can be associated with retention patterns. Careful modeling can bound or test explanations; it does not make incomplete data causal.
A reproducible multi-scenario exercise
Consider a hypothetical block whose initial prospective claim present value is 100, future expense present value is 15, relevant assets are 65, future currently scheduled premium present value is 45, and target risk provision is 5, all measured in consistent monetary units and at one valuation date. The diagnostic gap is 100 + 15 + 5 - 65 - 45 = 10. If every unit of future premium is eligible and behavioral reactions are ignored, a mechanical proportional indication is 10/45 = 22.22%. If only 30 units are eligible, the corresponding indication becomes 33.33%. These are different denominators, not competing discoveries about the same underlying insurer.
In a morbidity stress, suppose claim present value rises by 10 while all other parameters stay fixed. The gap becomes 20 and the indication on 45 eligible units rises to 44.44%. In an asset stress, suppose asset value falls by 5; the gap becomes 15 and the indication becomes 33.33%. In a joint stress, both changes create a gap of 25 and the indication becomes 55.56%. The exercise shows sensitivity, not probabilities or actual insolvency thresholds. All cases must use consistent accounting so that an explicit risk provision is not also concealed in another margin.
A policyholder response stress changes the model structurally. If an announced increase reduces future premium exposure and reduces claims by different fractions, the indicated percentage no longer follows the fixed-denominator equation. The analyst must recalculate expected cash flows after the RBO and lapse elections, not simply subtract an assumed shock-lapse percentage from the indicated rate. Selected policyholder behavior should be shown as scenario bounds when adequate empirical coefficients are missing.
Comparing regulatory outcomes without causal overclaiming
Suppose one state approves 25% promptly and another permits 15% phased in. The difference could reflect different laws, earlier cumulative increases, exposure composition, actuarial assumptions, insurer-negotiated commitments, or other facts. A descriptive comparison should align the same policy form, the cumulative rate path, and observed timing before comparing effective premiums. The New York public application summaries and California rate histories demonstrate the availability of partial public evidence; they do not alone resolve all omitted characteristics.
A credible empirical program could assemble matched filing histories from SERFF and state archives, recode rate approvals and benefit modifications, and model lapses and claims with cohort controls. Identification would still require explicit treatment of regulatory selection and unobserved insurer distress. Where administrative datasets are inaccessible, the appropriate output is a documented comparative audit rather than a fictional estimate.
Accounting, prudential, and legal validation
Source disciplines should be kept separate. IFRS 17 applies to insurance-contract financial reporting in adopting jurisdictions. ASOP 18 Long-Term Care governs actuarial LTC work within its stated professional scope, while ASOP 22 concerns asset adequacy opinions and ASOP 41 concerns actuarial communications. The IAIS supervisory framework supplies cross-jurisdiction institutional objectives. A complete actual filing review would additionally require the binding state law, issued forms, reserve regulations, actuarial memorandum, filings, and final approvals effective for the relevant date.
Document validity requires more than a working URL. A document can describe a proposal, a model, a draft, a completed report, or an enforceable rule, each with a different evidentiary status. For the present monograph, official NAIC model materials establish model history and the 2025 MSA governance mechanism, while the two state departments establish actual examples of their own public processes. Peer-reviewed papers support specific economic interpretations, and survey reports support observations about their contributing firms. No cross-source leap to a universal legal entitlement or uniform present-day rate is made.
Boundaries of the current evidence
This is a fundamental documentary and analytical monograph, not a census of insurer filings and not an independent re-estimation of proprietary claims experience. The 2024 rate survey is informative because of its industry coverage, but selection, aggregation rules, pending decisions, and the difference between filings and premium-weighted policy outcomes limit broad inference. The SOA–LIMRA persistency dataset supplies a historical industry frame, not post-2023 policy-specific lapse coefficients. Public international LTC comparisons describe care systems that differ in benefits, reporting boundaries, and financing. These limitations are part of the findings, not tasks deferred to a release step.
Integrated Findings and Research Agenda
The causal structure of a rate adjustment
The documentary and mathematical evidence supports a consistent account of the repricing chain. Original design fixes an expected financing path under assumptions and margins. Realized mortality, lapse, morbidity, investment income, care utilization, and expenses alter the emerging financial position. Experience and actuarial judgment generate updated projections; contracts and law determine what adjustments are available. The regulator evaluates a filing with due regard to sufficiency, fairness, prior changes, and communication. Policyholder elections then influence the actual cash-flow trajectory and future experience. This chain explains why repricing is a recursive governance process rather than the simple recalculation of a price.
An explicit historical bridge is critical. A filing supported only by new assumptions can be difficult to audit, while a filing supported only by an inherited loss-ratio target may fail to assess present sufficiency. The NAIC multistate framework combines history and prospective review, and the professional LTC standard situates the work in established actuarial practice. The synthesis calls for transparently reconciling these requirements without elevating them into a purportedly new pricing doctrine.
Rate stability as a set of observable outcomes
For a well-defined block, nominal rate stability can be measured by the number, frequency, and cumulative compound size of premium changes. Financial adequacy can be observed through prospective cash-flow sufficiency tests and appropriately scoped reserve or capital outcomes. Coverage stability can be studied through retained benefit amounts, inflation protection, lapse, contingent protection, and the distribution of RBO elections. Institutional stability can be assessed through review delay, clarity of decisions, consistency of treatment of comparable filings, and completeness of policyholder communication.
These metrics should be reported in parallel. A large premium increase that materially strengthens a block yet induces significant coverage reduction should not be described with one success indicator. Conversely, a freeze in premium adjustments may preserve short-run affordability yet defer the financing gap and create later pressure. Every conclusion needs a valuation horizon and reference population.
Market evidence and its interpretive constraints
The observed 2024 survey contrast between 56% requested and 28% approved increases is economically meaningful within the sampled filings, as documented by Milliman's 2025 survey report. The evidence demonstrates that filed needs and regulatory decisions regularly differ, and that time, jurisdiction, and benefit design matter. It does not establish which approvals were optimal, what future solvency will be, or the average lifetime increase paid by all existing U.S. policyholders.
The scholarship on private-information heterogeneity, Medicaid interaction, and lapsation is equally important for interpretation. Finkelstein and McGarry (2006) caution against reading selection from a single risk–coverage correlation; Brown and Finkelstein (2008) analyze the interaction of public and private financing; Friedberg and colleagues (2023) add evidence about vulnerability and policy termination. Together these sources demonstrate why an analytically complete rate review should take participation and welfare seriously rather than assume unchanged demand.
What regulators and researchers can actually verify
The strongest immediately implementable review practice is a transparent, dated evidence trail. Each substantial rate decision can be checked against the approved original rate table and benefit schedule, original experience assumptions and margins, observed exposure and decrement experience, updated model, stress tests, scope of approval, phasing terms, policyholder notice, and post-decision elections. This is a synthesis of existing actuarial controls and public documentation expectations rather than a novel institutional framework.
A jurisdictional comparison should describe the vintage of rules and policies. NAIC's model-regulation history demonstrates how rate-stabilized generations differ; New York's filing review description and California's rate-stabilization guidance show state-level operational interpretations. Transparent mapping improves the scientific credibility of rate comparisons and can help prevent misleading consumer communication.
Priority research gaps
The main empirical gap is access to matched, longitudinal microdata that follow original pricing assumptions, subsequent approvals, actual premium payments, benefit elections, lapsation, health transitions, and claims through time. Without these records, it is difficult to distinguish how much of an approval difference is attributable to legal practice, asset conditions, product mix, or unobserved selection. Public reports of the kind discussed here provide strong institutional context but incomplete causal identification.
A second gap is the joint response of policyholders to price and benefit modifications. The financial-planner interview research describes complex decision-making, and the industry rate survey quantifies respondent option selections. Additional research would measure outcomes and uncertainty by socioeconomic and functional status, without presuming that a declared choice maximizes welfare.
A third gap concerns the interaction between care-system change and insurance design. The OECD care workforce analysis and OECD long-term care expenditure definitions provide useful external conditions, but they do not reveal how a particular LTC policy's future insured benefits respond to labor shortages, public financing reform, or site-of-care substitution. This requires product-specific benefit translation and observational data.
Interpretation for international risk science
Long-duration LTC financing illustrates a general insurance problem: the original contract fixes or constrains a payment promise while future events continually revise the distribution of obligations. The value of actuarial information depends on how it is translated into financial management and lawful contract action. The U.S. rate-review experience offers an unusually documented environment for studying that translation, while the international standards support comparability of professional method and supervisory objective.
The transferable finding is methodological: define the contract, cohort, valuation date, risk-state transitions, legal authority, and consumer outcome before comparing rates. The strength of this finding rests on the convergence of documents and transparent cash-flow reasoning rather than a claim of discovering a universal law of insurance.
Conclusion
Long-term care premium rate stability is an intertemporal governance question arising from long-duration insurance promises. Premium adequacy depends on the joint evolution of claims, mortality, lapse, investments, care costs, expenses, and the insured population; policyholder security depends additionally on the legal continuity of benefits and the ability to sustain payments over time. Regulatory review must connect the original pricing basis to updated experience and must distinguish a supportable actuarial indication from the amount approved, implemented, and ultimately collected.
The historical NAIC regulation study and contemporary multistate rate review framework demonstrate how the supervisory response has moved toward documented assumptions, earlier monitoring, coordinated review, and consumer alternatives. The 2025 industry survey analysis shows that sizable rate requests, partial approvals, and varied product-level approaches remain relevant. The underlying market economics and observed lapses further establish that the policyholder's response is integral to both financial projections and welfare assessment.
This monograph's original contribution is its integrated source-to-claim interpretation and reproducible illustration of the analytical chain connecting initial assumptions, prospective sufficiency, legal review, and retained protection. Its findings remain bounded by the public documentary record, the observed research populations, and the stated illustrative assumptions. The enduring scientific task is to improve the evidence available at each link so that solvency, contract value, and the consequences of repricing can be evaluated together.
References
Actuarial Standards Board. (2010). Actuarial Standard of Practice No. 41: Actuarial Communications (effective 2011). https://www.actuarialstandardsboard.org/asops/actuarial-communications/
Actuarial Standards Board. (2016). Actuarial Standard of Practice No. 23: Data Quality. https://www.actuarialstandardsboard.org/asops/data-quality/
Actuarial Standards Board. (2021). Actuarial Standard of Practice No. 22: Statements of Actuarial Opinion Based on Asset Adequacy Analysis for Life Insurance, Annuity, or Health Insurance Reserves and Other Liabilities. https://www.actuarialstandardsboard.org/asops/asop-no-22-statements-of-actuarial-opinion-based-on-asset-adequacy-analysis-for-life-insurance-annuity-or-health-insurance-reserves-and-other-liabilities/
Actuarial Standards Board. (2022). Actuarial Standard of Practice No. 18: Long-Term Care (revised March 2022, effective September 1, 2022). https://www.actuarialstandardsboard.org/asops/asop-18-long-term-care/
Brown, J. R., & Finkelstein, A. (2007). Why is the market for long-term care insurance so small? Journal of Public Economics, 91(10), 1967–1991. https://doi.org/10.1016/j.jpubeco.2007.02.010
Brown, J. R., & Finkelstein, A. (2008). The interaction of public and private insurance: Medicaid and the long-term care insurance market. American Economic Review, 98(3), 1083–1102. https://doi.org/10.1257/aer.98.3.1083
Brown, J. R., & Finkelstein, A. (2009). The private market for long-term care insurance in the United States: A review of the evidence. Journal of Risk and Insurance, 76(1), 5–29. https://doi.org/10.1111/j.1539-6975.2009.01286.x
California Department of Insurance. (n.d.; accessed 2026). Long Term Care Insurance Rate History. https://www.insurance.ca.gov/01-consumers/105-type/95-guides/05-health/01-ltc/rate-history.cfm
California Department of Insurance. (n.d.; accessed 2026). Long Term Care Insurance: Consumer Guide. https://www.insurance.ca.gov/01-consumers/105-type/95-guides/05-health/01-ltc/ltc-insurance.cfm
Cude, B. J., Groshong, L., & Burns, B. (2022). Long-term care insurance rate increases and reduced benefit options: Insights from interviews with financial planners. NAIC Center for Insurance Policy and Research. https://content.naic.org/sites/default/files/long-term-care-insurance-rate-increases-and-reduced-benefit-options-insights-from-interviews-with-financial-planners.pdf
Finkelstein, A., & McGarry, K. (2006). Multiple dimensions of private information: Evidence from the long-term care insurance market. American Economic Review, 96(4), 938–958. https://doi.org/10.1257/aer.96.4.938
Friedberg, L., Hou, W., Sun, W., & Webb, A. (2023). Lapses in long-term care insurance. Journal of Risk and Insurance, 90(3), 569–595. https://doi.org/10.1111/jori.12425
IFRS Foundation. (2023; accessed 2026). IFRS 17 Insurance Contracts: Issued standard overview. https://www.ifrs.org/issued-standards/list-of-standards/ifrs-17-insurance-contracts/
International Association of Insurance Supervisors. (accessed 2026). Insurance Core Principles and ComFrame online tool. https://www.iais.org/icp-online-tool/
Milliman. Bergerson, M., Duxbury, A., & Kronlokken, C. (2025, April 14). Long-term care rate increase survey: 2024 survey report and findings. https://www.milliman.com/en/insight/long-term-care-rate-increase-survey
National Association of Insurance Commissioners. (n.d.; accessed 2026). Model Laws: Long-Term Care Insurance Models 640–643. https://content.naic.org/model-laws
National Association of Insurance Commissioners. (2016). The State of Long-Term Care Insurance: The Market, Its Challenges and Future Innovations. Center for Insurance Policy and Research Study Series 2016-1; see Regulation of Long-Term Care Insurance Rates. https://content.naic.org/sites/default/files/inline-files/cipr_current_study_160519_ltc_insurance_0.pdf
National Association of Insurance Commissioners. (2025, December). Long-Term Care Insurance Multistate Rate Review Framework. Health Actuarial (B) Task Force. https://content.naic.org/sites/default/files/documents/ltci-msa-framework.pdf
National Association of Insurance Commissioners. (2026). Long-Term Care Insurance: Insurance Topics overview, updated July 23, 2026. https://content.naic.org/insurance-topics/long-term-care-insurance
National Association of Insurance Commissioners. (2026). Long-Term Care Actuarial (B) Working Group: 2026 charges. https://content.naic.org/committees/b/long-term-care-actuarial-wg
National Association of Insurance Commissioners. (accessed 2026). Long-Term Care Insurance Multistate Rate Review: Process and resources. https://content.naic.org/industry/long-term-care-insurance-multistate-rate-review
National Association of Insurance Commissioners. (accessed 2026). Consumer Long-Term Care Insurance information. https://content.naic.org/consumer/long-term-care-insurance.htm
New York State Department of Financial Services. (accessed 2026). Long Term Care: Methodology for Review and Analysis of LTC Rate Applications. https://www.dfs.ny.gov/consumers/health_insurance/long_term_care_insurance/methodology_review_analysis_ltc_rate_apps
New York State Department of Financial Services. (accessed 2026). Consumer Guide to Long Term Care Insurance. https://www.dfs.ny.gov/consumers/health_insurance/long_term_care_insurance/consumer_guide
New York State Department of Financial Services. (2024–2026). Long Term Care Premium Rates: Public application summaries. https://myportal.dfs.ny.gov/en/web/prior-approval/ltc
Noel, C., & Williamson, C. (2025, April). LTC Rate Increase Landscape Update. Society of Actuaries, Long-Term Care News. https://www.soa.org/sections/long-term-care/long-term-care-newsletter/2025/ltc-2025-04-noel-williamson/
Organisation for Economic Co-operation and Development. (2025). Health at a Glance 2025: Long-Term Care Spending and Unit Costs. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/long-term-care-spending-and-unit-costs_59f07562.html
Organisation for Economic Co-operation and Development. (2025). Health at a Glance 2025: Long-Term Care Workers. https://www.oecd.org/en/publications/health-at-a-glance-2025_8f9e3f98-en/full-report/long-term-care-workers_9c3bdbaf.html
Society of Actuaries Research Institute. (2021). 2000–16 Individual Long-Term Care Policy Persistency: Lapse and Mortality Rates Report (SOA–LIMRA). https://www.soa.org/resources/experience-studies/2021/ltc-policy-persistency/
Society of Actuaries Research Institute. (accessed 2026). Long-Term Care Experience Studies: Study and table catalog. https://www.soa.org/research/topics/ltc-exp-study-list/
Society of Actuaries Research Institute. (2025). 2000–2023 Long-Term Care Data Request: Stand-alone LTC insurance experience study scope. https://www.soa.org/research/opportunities/2025/2000-23-ltc-datarequest/